Research & Development News summary
Antioxidant tested as therapy
for oesophagitis Antioxidants should be considered as supplementary
therapy in the treatment and prevention of reflux oesophagitis, a new
study shows...[more]
Inhibiting glutamate: a treatment for brain tumours?
Inhibiting the secretion of glutamate, an amino acid neurotransmitter,
could provide a new approach to treating brain tumours, American researchers
say...[more]
Vaccine developed for leishmaniasis A
novel DNA vaccine against leishmaniasis has been developed by researchers
at the National Institute of Allergy and Infectious Diseases, United States...[more]
Flaxseed protects against postmenopausal breast
cancer Eating flaxseed could protect postmenopausal women against
breast cancer, say researchers from the United States...[more]
Developing an oral insulin preparation A
new delivery system for administering insulin orally was reported on 26
August at a meeting of the American Chemical Society in Chicago...[more]
Compound stops autoimmune response in diabetes
A compound that might be useful for treating autoimmune diseases
mediated by pathogenic T-helper type 1 (Th1) cells has been identified...[more]
Promising phase II results for immunosuppressant
FTY720, an immunosuppressant drug undergoing phase II trials,
appears to be as effective as currently available drugs but could have
a different mode of action...[more]
New antimalarial shows promise in animal studies
A new antimalarial drug has been shown to be effective in studies
conducted on rodents by researchers from the United States...[more]
|
